RFK Jr. and Vance Refer Hospitals to DOJ and HHS IG Over Alleged Federal Law Violations
Health and Human Services Secretary Robert F. Kennedy Jr. and Vice President JD Vance announced that a new Department of Health and Human Services (HHS) review has led to the referral of certain hospitals and clinics to the U.S. Department of Justice (DOJ) and the HHS Inspector General for possible violations of federal law Ground News.
According to the announcement, the review is tied to a new HHS report titled “Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of ‘Gender Medicine’”. The report, as described in media coverage, identifies a number of medical institutions and providers that, according to the administration, have engaged in what they call “gender-related” procedures for minors, including the use of puberty‑blocking drugs and other treatments, and have allegedly profited from these services Ground News.
Vance said the findings have prompted criminal investigations, and he called for prosecution of both “health” facilities and physicians involved, framing the issue as a case of “fraud” and “mutilating procedures” targeting children Ground News. He also noted that the report revealed hospitals had billed insurance companies tens of millions of dollars for such treatments Ground News.
Kennedy, in his role as HHS Secretary, confirmed that the identified facilities have been referred to the DOJ and the HHS Inspector General for further review. The HHS Inspector General’s office is responsible for investigating possible misuse of federal funds, fraud, abuse, or other violations of law within HHS programs Ground News.
The administration’s position is that these actions may have violated federal statutes, and that the DOJ will determine whether criminal charges are warranted. The HHS IG will assess whether there are systemic issues, improper billing, or other unlawful practices tied to the identified providers Ground News.
This move comes amid broader policy shifts under Kennedy’s leadership at HHS, which have included significant changes to public health programs and positions on various medical issues PBS+1. The referral of these facilities to law enforcement and oversight bodies underscores the administration’s emphasis on pursuing alleged wrongdoing through legal channels.
Vice President JD Vance spoke about a recent report on gender affirming care for minors and how hospitals billed this care to insurance. Stay Connected Forbes Breaking News on X: https://x.com/ForbesTVNews Forbes Breaking News on TikTok: / forbestvnews More From Forbes: http://forbes.com
⭐ Key Takeaways
- HHS released a commissioned report alleging that some hospitals and clinics used incorrect or misleading insurance codes to bill for gender‑related medical interventions on minors.
- The report claims financial incentives and coding practices may have obscured the nature of treatments, including puberty blockers and other interventions.
- Over 225 hospitals/health systems are described as having pediatric gender programs.
- Insurance claims data from 2015–2025 reportedly show tens of millions of dollars billed under codes such as E34.9 (Endocrine Disorder, Unspecified) and E301 (Precocious Puberty).
- Vice President JD Vance and HHS Secretary Robert F. Kennedy Jr. announced referrals to the Department of Justice and HHS Office of Inspector General for potential legal violations.
- Senior officials (CMS Administrator Mehmet Oz, Assistant Secretary Brian Christine) emphasized oversight, lawful billing, and concerns about irreversible interventions.
- The report recommends greater scrutiny, investigations, and policy review of pediatric gender‑medicine practices.
🧭 Policy Implications: What This Report Signals
- Increased Federal Scrutiny of Pediatric Gender Medicine
The referrals to DOJ and OIG indicate a shift toward criminal and civil enforcement rather than purely regulatory oversight. Implication:
- Hospitals may face audits, investigations, and potential fraud allegations if billing practices are found to violate federal law.
- Potential Revisions to Insurance Coding Standards
The report’s focus on ICD‑10 codes suggests future efforts to:
- Clarify which codes can be used for gender‑related treatments.
- Prevent use of broad or ambiguous codes for specialized interventions. Implication:
- Insurers and providers may need to adopt stricter documentation and coding compliance protocols.
- Shift in Federal Health‑Policy Priorities
The messaging from HHS leadership frames pediatric gender interventions as a matter of:
- Medical ethics
- Financial transparency
- Child protection Implication:
- Federal agencies may pursue new regulations, guidance documents, or funding restrictions related to pediatric gender care.
- Legal Exposure for Hospitals and Health Systems
If DOJ or OIG investigations proceed, hospitals could face:
- False Claims Act cases
- Civil monetary penalties
- Loss of federal program eligibility Implication:
- Health systems may reassess or pause certain pediatric gender‑care services to mitigate risk.
- Impact on State‑Level Policy
States often follow federal cues. This report may:
- Encourage states to tighten Medicaid billing rules.
- Influence legislative debates on pediatric gender care. Implication:
- Expect more state‑level bills addressing insurance coverage, reporting requirements, or restrictions.
- Changes in Public Health Program Oversight
CMS’s involvement signals possible changes to:
- Medicaid/CHIP reimbursement rules
- Auditing procedures Implication:
- Providers may face more frequent audits and pre‑authorization requirements for treatments involving minors.
- Broader Cultural and Political Effects
Because gender‑related medical care is already politically charged, the report may:
- Intensify national debate
- Influence advocacy groups on both sides Implication:
- Public discourse may shift toward financial accountability and medical oversight, rather than solely ideological framing.
🔍 Bottom Line
The report is not just a critique of medical practice; it is a policy signal. It suggests the federal government may pursue a multi‑agency crackdown on billing practices associated with pediatric gender medicine, with potential ripple effects across healthcare compliance, insurance regulation, and state policy.
The full report, Wolves in White Coats: How Doctors and Hospitals Pushed and Profited from the Fraud of “Gender Medicine,” is available here [PDF, 3.70 MB].
The Executive Summary of the report is available here [PDF, 943 KB].
HHS Releases Report Exposing Fraudulent Insurance Coding For Sex-rejecting Procedures On Minors
